Vor Biopharma Closes $110 Million Series B Financing " Vor Biopharma
Proceeds will advance the company's lead program into clinical trials and expand the portfolio CAMBRIDGE, Mass., - July 7, 2020 - Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced it has raised $110 million in a Series B financing.
Labels
Thursday, 9 July 2020
Startup Funding Alert: Vor Biopharma Closes $110 Million Series B Financing
Tuesday, 7 July 2020
The Chennai-based startup MicroGo's IoT-enabled hand hygiene device is seeing high demand amidst COVID-19
This Chennai-based startup's IoT-enabled hand hygiene device is seeing high demand amidst COVID-19
MicroGo, a Chennai-based biotech startup, has seen a rise in installations of its IoT (Internet of Things) enabled hand hygiene device during the coronavirus pandemic. Founder Rachna Dave claims that it has installed around 180 units of its GO assure device since March 2, 2020, across various cities.
Wednesday, 1 July 2020
Startup Funding Alert: French-American AI startup Owkin closes $18 million Series A to make medical research more collaborative - Tech.eu
French-American AI startup Owkin closes $18 million Series A to make medical research more collaborative - Tech.eu
Owkin, a French company applying machine learning to medical research, has secured $18 million in funding from Mubadala Capital and Bpifrance, through the bank's Large Venture fund. This Series A extension brings the startup's total amount raised to $70 million. The AI platform connects data scientists, clinicians, academic researchers and pharmaceutical companies to create global ...
Tuesday, 30 June 2020
Covi-19: Bharat Biotech's Covid vaccine gets DCGI nod for clinical trials
Bharat Biotech's Covid vaccine gets DCGI nod for clinical trials
Indian vaccine manufacturer Bharat Biotech has announced obtaining the approvals of the Drug Controller General of India to initiate phase-I and II human clinical trials for the vaccine candidate for Covid-19 it developed in collaboration with the National Institute of Virology, part of the Indian Council of Medical Research.